Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05) - Susanne Krege, Heidrun Rexer, Frank vom Dorp, Patrick de Geeter, Theodor Klotz, Margitte Retz, Axel Heidenreich, Michael Kühn, Joern Kamradt, Christian Wülfing, Stefan Zastrow, Oliver Hakenberg, Jan Roigas, Hans Heinzer, Mark Schrader - Dissemin

Language
Login

Published in

Wiley, BJU International, 3(113), p. 429-436, 2014

DOI: 10.1111/bju.12437

Links

Tools

Export citation

Search in Google Scholar

Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)

Journal article published in 2014 by Susanne Krege, Heidrun Rexer, Frank vom Dorp, Patrick de Geeter, Theodor Klotz, Margitte Retz, Axel Heidenreich, Michael Kühn, Joern Kamradt, Christian Wülfing, Stefan Zastrow, Oliver Hakenberg, Jan Roigas, Hans Heinzer, Mark Schrader and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO